T-cell gene therapy successful in early clinical trial
Researchers trialling a gene therapy-based treatment for leukemia have said the early results go beyond anything they could have thought of in their 'wildest dreams'...
Chris Hardy was previously a Volunteer Writer at BioNews, having originally joined the publication under the auspices of its writing scheme. He is currently undertaking a PhD at the Dementia Research Centre at University College London (UCL) under the supervision of Professor Jason Warren and Professor Sebastian Crutch. He is focussing on understanding the mechanisms of auditory signal decoding in the primary progressive aphasias: subtypes of dementia that predominately affect language processing and comprehension. His research combines behavioural, structural and functional neuroimaging approaches and is supported by a Medical Research Council studentship. Previously, he studied Psychology at the University of Exeter, and went on to obtain a MSc at UCL's Institute of Cognitive Neuroscience.
by Chris Hardy
Researchers trialling a gene therapy-based treatment for leukemia have said the early results go beyond anything they could have thought of in their 'wildest dreams'...
by Chris Hardy
Genetics plays a role in male sexual orientation but social and environmental factors are also involved, research suggests...
by Chris Hardy
Stem cells have reversed the equivalent of type 1 diabetes in genetically modified mice. Using skin cells as a starting point, researchers formed pancreas precursor cells that produced insulin when injected into mice...
by Chris Hardy
Fertility experts have warned that IVF is overused and is too often recommended to couples who may not need it...
by Chris Hardy
Genetic mutations implicated in autism and intellectual difficulties may also underlie schizophrenia, say researchers...
Join our list to stay up-to-date on all the latest developments in the fields of human fertility and genomics.